• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

作者信息

Pérez-Trallero E, Garcia-Arenzana J M, Jimenez J A, Peris A

出版信息

Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):905-6. doi: 10.1007/BF01967510.

DOI:10.1007/BF01967510
PMID:2073905
Abstract
摘要

相似文献

1
Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.环丙沙星治疗肺炎球菌肺炎时的治疗失败及对喹诺酮类药物耐药性的选择
Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):905-6. doi: 10.1007/BF01967510.
2
Therapeutic effect of oral levofloxacin, ciprofloxacin, and ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations of the quinolones are similar.口服左氧氟沙星、环丙沙星和氨苄西林对由青霉素中介肺炎链球菌引起的实验性小鼠肺炎的治疗效果，其中喹诺酮类药物的最低抑菌浓度相似。
Chemotherapy. 1999 May-Jun;45(3):183-91. doi: 10.1159/000007181.
3
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.环丙沙星、氧氟沙星和替马沙星在实验性小鼠肺炎模型疾病不同阶段的抗肺炎球菌活性。
J Infect Dis. 1991 Feb;163(2):319-24. doi: 10.1093/infdis/163.2.319.
4
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.对左氧氟沙星的耐药性与肺炎球菌肺炎治疗失败
N Engl J Med. 2002 Mar 7;346(10):747-50. doi: 10.1056/NEJMoa012122.
5
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.对左氧氟沙星的耐药性与肺炎球菌肺炎治疗失败
N Engl J Med. 2002 Jul 4;347(1):65-7; author reply 65-7. doi: 10.1056/NEJM200207043470115.
6
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.对左氧氟沙星的耐药性与肺炎球菌肺炎治疗失败
N Engl J Med. 2002 Jul 4;347(1):65-7; author reply 65-7.
7
[New quinolones for the treatment of community-acquired pneumonia--pro].
Dtsch Med Wochenschr. 2003 May 9;128(19):1070. doi: 10.1055/s-2003-39104.
8
Antibiotic-resistant pneumococci.耐抗生素肺炎球菌
Commun Dis Rep CDR Wkly. 1992 May 15;2(20):89.
9
[New quinolones for the treatment of community-acquired pneumonia--contra].[用于治疗社区获得性肺炎的新型喹诺酮类药物——禁忌]
Dtsch Med Wochenschr. 2003 May 9;128(19):1071. doi: 10.1055/s-2003-39105.
10
Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone.香港肺炎链球菌对氟喹诺酮类药物的耐药性与西班牙23F克隆株有关。
Emerg Infect Dis. 2001 Sep-Oct;7(5):906-8. doi: 10.3201/eid0705.010526.

引用本文的文献

1
Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection.核苷酸取代在数十年来血清型 3 肺炎球菌的多样化以及在单次感染过程中的主导作用。
PLoS Genet. 2013;9(10):e1003868. doi: 10.1371/journal.pgen.1003868. Epub 2013 Oct 10.
2
Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.西班牙7价结合疫苗接种后耐氟喹诺酮肺炎链球菌的变化
Emerg Infect Dis. 2009 Jun;15(6):905-11. doi: 10.3201/eid1506.080684.
3
Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.

本文引用的文献

1
In vitro activity of ciprofloxacin against gram-positive cocci.环丙沙星对革兰氏阳性球菌的体外活性。
Am J Med. 1987 Apr 27;82(4A):27-32.
2
In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.环丙沙星对一家南欧医院分离出的需氧菌的体外活性。
Antimicrob Agents Chemother. 1987 Oct;31(10):1651-5. doi: 10.1128/AAC.31.10.1651.
3
Penetration of ciprofloxacin into bronchial secretions.环丙沙星在支气管分泌物中的渗透情况。
具有拓扑异构酶IV重组基因的肺炎链球菌氟喹诺酮耐药菌株的适应性
Antimicrob Agents Chemother. 2008 Mar;52(3):822-30. doi: 10.1128/AAC.00731-07. Epub 2007 Dec 26.
4
Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.下呼吸道感染患者氟喹诺酮类药物的选择指南。
Drugs. 2005;65(7):949-91. doi: 10.2165/00003495-200565070-00004.
5
Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.西班牙青霉素耐药肺炎链球菌克隆株中的氟喹诺酮耐药性
Emerg Infect Dis. 2004 Oct;10(10):1751-9. doi: 10.3201/eid1010.040382.
6
Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates.肺炎球菌肺炎中氟喹诺酮类和大环内酯类治疗失败及多重耐药菌株的选择
Emerg Infect Dis. 2003 Sep;9(9):1159-62. doi: 10.3201/eid0909.020810.
7
Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.草绿色链球菌是拓扑异构酶IV基因向肺炎链球菌进行水平转移的供体。
Antimicrob Agents Chemother. 2003 Jul;47(7):2072-81. doi: 10.1128/AAC.47.7.2072-2081.2003.
8
Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis.从一名支气管扩张患者的环丙沙星治疗期间分离出的耐氟喹诺酮肺炎链球菌菌株的基因特征分析
Antimicrob Agents Chemother. 2003 Apr;47(4):1419-22. doi: 10.1128/AAC.47.4.1419-1422.2003.
9
Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.肺炎链球菌临床分离株中导致氟喹诺酮耐药性的突变的遗传分析。
Antimicrob Agents Chemother. 2001 Dec;45(12):3517-23. doi: 10.1128/AAC.45.12.3517-3523.2001.
10
Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.肺炎链球菌氟喹诺酮耐药临床分离株中parC和gyrA的水平转移
Antimicrob Agents Chemother. 2000 Apr;44(4):840-7. doi: 10.1128/AAC.44.4.840-847.2000.
Eur J Clin Microbiol. 1986 Apr;5(2):197-200. doi: 10.1007/BF02013986.
4
Clinical use of the quinolones.喹诺酮类药物的临床应用。
Lancet. 1987 Dec 5;2(8571):1319-22. doi: 10.1016/s0140-6736(87)91205-0.